Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00298870
Status:
COMPLETED
Last Update Posted:
2012-10-18
First Post:
2006-03-02
Brief Title:
Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy RT-PGTT
Sponsor:
Osaka University
Organization:
Osaka University
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to elucidate whether the individualized medicine based on NAT2 gene polymorphism could improve the safety efficacy and economical benefits of multi-drug therapy for the pulmonary tuberculosis with isoniazid
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None